Skip to Content

Viveve Medical Inc VIVE

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

VIVE is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$4.79
Uncertainty
Extreme
1-Star Price
$6.54
5-Star Price
$4.78
Economic Moat
Smhj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if VIVE is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.11
Bid/Ask
$0.04 / $0.06
Market Cap
$4,289.54
Volume/Avg
4,352 / 3,008

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Viveve Medical Inc designs, develops, manufactures and markets a platform medical technology. Its Cryogen-cooled Monopolar Radiofrequency technology is delivered through a radiofrequency generator, handpiece and treatment tip, called the Viveve System. The Viveve System is for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The Viveve System is indicated for use and being marketed for use in general surgical procedures for electrocoagulation and hemostasis in the United States. It has a business presence in the US, Asia Pacific, Canada, Europe and Middle East and Latin America.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
47

Valuation

Metric
VIVE
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
VIVE

Financial Strength

Metric
VIVE
Quick Ratio
0.62
Current Ratio
0.89
Interest Coverage
−19.09
Quick Ratio
VIVE

Profitability

Metric
VIVE
Return on Assets (Normalized)
−97.99%
Return on Equity (Normalized)
−196.97%
Return on Invested Capital (Normalized)
−121.70%
Return on Assets
VIVE
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
SznwfvxrqXjllgxz$178.7 Bil
Stryker Corp
SYK
PnltwlqhgBpfbl$127.0 Bil
Boston Scientific Corp
BSX
HhrwfhggjJvnhp$114.9 Bil
Medtronic PLC
MDT
KmxpmpyWjwjnzh$100.1 Bil
Edwards Lifesciences Corp
EW
QnqdxbyfgYsztkv$52.9 Bil
DexCom Inc
DXCM
PcmnyzntbWcs$46.0 Bil
Koninklijke Philips NV ADR
PHG
PsrcvpllmHjfbp$24.3 Bil
Steris PLC
STE
SxxshjxbDzlst$22.5 Bil
Zimmer Biomet Holdings Inc
ZBH
KkpjyfncxFtdnd$22.1 Bil
Align Technology Inc
ALGN
TvlhqrbvdNpzwdf$18.6 Bil

Sponsor Center